AstraZeneca China Chief Detained Amid Investigative Probes Business 8 November 2024 In recent developments, AstraZeneca has confirmed the detention of its China chief, Leon Wang, amidst a backdrop of investigative probes.…
AstraZeneca’s Strategic Move $2bn Dyslipidemia Drug Licensing Business 8 October 2024 AstraZeneca has embarked on a significant venture, underscoring its commitment to cardiovascular health. With a $2 billion licensing agreement, the…
AstraZeneca and UK Treasury in Positive Talks About £450m Vaccine Facility Business 9 September 2024 The UK Treasury and AstraZeneca are reportedly engaged in constructive negotiations regarding the future of a planned £450 million vaccine…
Major corporations return to CBI as lobby group rebuilds after misconduct scandal Business 26 August 2024 Several prominent corporations have decided to rejoin the Confederation of British Industry (CBI) following a significant misconduct scandal. The CBI…
FDA Endorses AstraZeneca’s Imfinzi for Early-Stage Lung Cancer Treatment Business 16 August 2024 AstraZeneca’s innovative drug, Imfinzi, now has the US FDA’s approval for treating early-stage lung cancer. This marks a significant milestone…
